Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal. Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured...
Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal. Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured...
